NIH grants seek best ways to combine genomic information and EHRsFull article w/grantee information here.
Researchers seek to better understand genomic basis of disease, provide tailored care to patients
Bethesda, Maryland, Tues., September 1, 2015 - A dozen awards from the National Institutes of Health will support research that incorporates DNA sequence information into electronic medical records. The goal of research conducted by the Electronic Medical Records and Genomics (eMERGE) network is to better understand the genomic basis of disease and to tailor medical care to individual patients based on their genomic differences.
The grants, administered by the National Human Genome Research Institute (NHGRI), represent the third phase of the eMERGE program, and focus on moving genomics research closer to clinical application by identifying the potential medical effects of rare genomic variants (inherited differences in the DNA code) in about 100 clinically relevant genes. The activity of such genes can affect a person's health, and might affect treatment choices.
"The newly funded projects are focused on discovering genes and gene variants with clinical implications by using the latest sequencing technologies to examine rare and common variants suspected to relate to disease risk and treatment effects," said Rongling Li, M.D., Ph.D., program director for eMERGE in the Division of Genomic Medicine at NHGRI, a part of NIH. "The other important component of these grants is implementing what researchers learn about these gene variants into medical settings to improve patient care."
Researchers will look at the best ways to provide DNA test results to physicians and patients, she said, and ways in which doctors might use this information to improve clinical treatment and practice. These funded researchers will also examine the psychological and economic effects on patients and families, and the effects on healthcare systems, in using this information...
I direct you to a number of my prior posts on the "Omics" topical issues:
Are EHRs obsolete? (Aug 6th)
- Will commercial ("clinical") "omics" assays be sufficiently, uniformly accurate and precise?
- Will clinical staff be adequately up to speed on "omics" dx analytics and tx options, and how will all of this fit into workflows?
- Will Health IT capacity and functionality on the street suffice uniformly, or will we have a digital "omics divide" for a long time?
More to come...